SD
Sarah Dellomo
Director Of Client Services at Illuminas
View Sarah's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Director Of Client Services
Mar 2023 - Present · 1 years and 9 months
Director, Client Success
Jun 2019 - Jul 2022 · 3 years and 1 months
Account Executive
Jun 2007 - Jun 2019 · 12 years
Company Details
51-200 Employees
Illuminas is a multi-disciplinary consultancy with proprietary research methodologies and deep industry expertise to bridge gaps in understanding customers. Our insights empower the visionaries, shaping the future with customer-centric insights. In a world where every company is technology-led, clients trust us to illuminate their path to success and spotlight the most promising customer outcomes. Whether you are trying to identify key market trends, solve critical business issues or create leading brand strategies, our team of expert research consultants will recommend the most appropriate combination of quantitative and qualitative research tools to meet your needs. The biggest and most successful companies in the world come to us because we understand their business needs, and we reach beyond the data to tell the story behind the research. Illuminas Austin is a leading global insights consultancy that caters to B2B and consumer technology-driven industries. The London office is focused specifically on the finance, transport and distribution, and public sector industries.
Year Founded
2002
Social Media
LinkedinTwitter
Industry
Market Research
HQ Location
3801 South Capital of TX HWY Suite 200 Austin, TX 78704, US
Keywords
Market ResearchSurvey researchFocus group researchMessage testingB2B TechnologyBuyer Persona ResearchCustomer journey studiesMarket segmentation researchJTBD studiesVoice of the Customer research
Discover More About Cleveland Clinic

Find verified contacts of Sarah Dellomo in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.